Skip to main content
. 2014 Aug 2;6:711–718. doi: 10.2147/IJWH.S65481

Figure 2.

Figure 2

Change from baseline to cycle 6 in the average of the three highest VAS values on cycle days 22–28, for the hormone withdrawal-associated symptoms of headache or pelvic pain, in women who received treatment with E2V/DNG compared with (A) triphasic EE/NGM and (B) EE/LNG.

Notes: (A) Reproduced from Jensen JT, Parke S, Mellinger U, et al, Eur J Contracept Reprod Health Care, 2013;18(4):274–283, Copyright © 2013, Informa Healthcare. Reproduced with permission of Informa Healthcare.17 (B) Reproduced from Macìas G, Merki-Feld GS, Parke S, et al, J Obstet Gynaecol, 2013;33(6):591–596, Copyright © 2013, Informa Healthcare. Reproduced with permission of Informa Healthcare.31

Abbreviations: DNG, dienogest; E2V, estradiol valerate; EE, ethinyl estradiol; LNG, levonorgestrel; NGM, norgestimate; SD, standard deviation; VAS, visual analog scale.